Theriva Biologics
TOVX
TOVX
60 hedge funds and large institutions have $60.8M invested in Theriva Biologics in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
5% less capital invested
Capital invested by funds: $64.2M → $60.8M (-$3.39M)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Holders
60
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$150K | |
| 2 | +$121K | |
| 3 | +$62K | |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
+$58K |
| 5 |
RCP
Rothschild Capital Partners
New York
|
+$52K |
Top Sellers
| 1 | -$226K | |
| 2 | -$181K | |
| 3 | -$92K | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$80K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$66.7K |